Rezolute, Inc. announced the appointment of Gil Labrucherie to its Board of Directors (“Board”) where he will serve as Chairman of the Audit Committee. Mr. Labrucherie is currently the Chief Operating Officer and Chief Financial Officer of Nektar Therapeutics. Mr. Labrucherie brings nearly 25 years of senior leadership experience in finance, legal and corporate development to the Board.